program
We’re thrilled to share the program for Asia-Pacific Glaucoma Congress 2022.
In 2022 – the congress program will not only include the APGC sessions but MSJOC sessions as well!
It is important to note that in 2022 – the program will look slightly different:
- Thursday / Friday – fully virtual
- Saturday / Sunday – hybrid
The congress program is scheduled in GMT+8, Kuala Lumpur time zone. To check the program times in your location please use this handy convertor.
Speakers and topics will be updated here – please be sure to check back regularly.
| Day 1 - Thursday 4 August | |||||
|---|---|---|---|---|---|
|
Virtual sessions only |
|||||
|
0900-1030 |
APGC abstract session 1 |
||||
|
Chairperson: Visanee Tantisevi and Vijaya Lingham
|
|||||
|
Prospective Multicentre Trial of iStent infinite Trabecular Micro-Bypass in Glaucoma Uncontrolled by Prior Surgical or Medical Therapy
Robert Ang Complications and Post-operative Interventions after XEN45 Gel Stent Implantation in the Treatment of Open Angle Glaucoma – A Meta Analysis Bjorn Betzler Combined Ab-interno Canaloplasty (ABiC) in open and angle closure glaucoma: 12 month outcomes Jason Cheng Comparison of extended depth of focus and monofocal intraocular lenses in glaucomatous eyes Nathan Kerr Comparative study of 2-year outcomes for Hydrus or iStent inject microinvasive glaucoma surgery implants with cataract surgery Colin Clement Comparison of Short-Term Clinical Outcome between Ahmed Valve Implant versus Non-valved Paul implant in Malaysian Glaucoma patients Sze Lian Loh Intraocular Pressure Control After Trabeculectomy with Intraoperative Subtenon Injection of Mitomycin – C Pir Salim Mahar Dual Blade Goniotomy in Addition to Usual Fenestrating Slits to Enhance Early Intraocular Pressure Lowering in Non-Valved Aqueous Shunt Surgery for Primary Open Angle Glaucoma Mary Qiu Comparison of choroidal thickness after topical prostaglandin therapy in primary open angle glaucoma patients- a case series Gajashree S Online Perimetry: Validation, comparison with standard automated perimetry and patient appraisal Simon Skalicky Incidence of Hypotony Post Glaucoma Drainage Device Implantation: Paul vs Baerveldt Melissa Pei Yin Wang Q&A |
|||||
|
1030-1100 |
Break |
||||
|
1100-1230 |
American Glaucoma Society (AGS) symposium: Best of AGS |
||||
|
Chairpersons: Pradeep Ramulu and Pratap Challa
|
|||||
|
The LiGHT Trial: 6-Year Follow-Up Results
Evgenia Konstantakopoulou Rate of Visual Field Progression among Participants who developed POAG in Phase 1 or 2 in the Ocular Hypertension Treatment (OHTS) Study James Brandt Visual Field Outcomes from the Randomized, Multicenter, HORIZON trial Giovanni Montesano Effectiveness of Micro-invasive Glaucoma Surgery in the United States: IRIS Registry Longitudinal Analysis 2013-2018 Shuang-An Yang Genetic Factors Associated with Primary Open Angle Glaucoma (POAG) in the Ocular Hypertension Treatment Study (OHTS) John Fingert Prospective, Randomized, Multicenter, Open-label, 12-Month Evaluation of the Effectiveness and Safety of the Gel Stent vs Trabeculectomy: the Gold Standard Pathway Study (GPS) Arsham Sheybani Q&A |
|||||
|
1230-1300 |
Break |
||||
|
1300-1430 |
World Glaucoma Association (WGA) symposium: Bleb and non-bleb based surgeries: pearls from international experts |
||||
|
Chairpersons: Kaweh Mansouri and Tanuj Dada
|
|||||
|
Micropulse TLT: Clinical pearls for the best results
Jose Martinez de la Casa Canaloplasty or Goniotomy: which is best? Inder Paul Singh Stenting: how to make them work for the patient Kyung Rim Sung XEN: Inside Out vs.Outside In? Kaweh Mansouri TRABS: Best practices for successful outcomes Paul Healey Tubes: optimising your outcomes Da Wen Lu Q&A |
|||||
|
1430-1500 |
Break |
||||
|
1500-1630 |
APGC Film Festival |
||||
|
Chairpersons: Joseph A. Tumbocon and Do Tan
|
|||||
|
How to do Guided Implantation of Ahmed Glaucoma Valve and Its Usefulness
Chang Kyu Lee Does Size Matter? Yong Zheng Wai Releasable Suture in Trabeculectomy - A Boon to Glaucoma Rishika Lakshminarayana Surgical techniques for management of hypotonic maculopathy Nidhi Chauhan XEN Resuscitation: Management of complications Suho Lim Novel Use of the Intra-Operative Optical Coherence Tomography in Trabecular Bypass Minimally Invasive Glaucoma Surgery Bryan Ang A start to Trabectome Surgery: Must know tips and tricks! Sahebaan Sethi The Do-It-Yourself, Novel, Safe & Cost-Effective Diagnostic Cubicle for Glaucoma Practice in The COVID-19 Era Prasanna Venkatesh Ramesh Tailoring the Tube – Managing complications of Glaucoma Drainage Devices. Amit Pandey Affordable MIGS- Training & Surgery Smita Narayanan Q&A |
|||||
|
1630-1700 |
Break |
||||
|
1700-1830 |
Normal pressure glaucoma
|
||||
|
Chairperson: Mimiwati Zahari and David Wen Wei Woo
|
|||||
|
OCTA in NTG
Lan-Hsin Chuang Cognitive impairment in NTG Puspha Raman Risk factors associated with progression in normal-tension glaucoma: systemic blood pressure Hyoung Won Bae Risk factor of progression in NTG with lower IOP controlled under 13mmHg Rei Sakata Special attention to disc hemorrhage in NTG Kazuhisa Sugiyama NTG- and metabolic syndrome Virna Dwi Oktariana Asrory Obesity, nutrient supply and glaucoma Joon Kim Q&A |
|||||
|
1830-1930 |
Industry symposium: Introducing Hydrus® Microstent Into your Clinical Practice Moderator: Chelvin Sng Introduction and Opening Remarks Moderator: Chelvin Sng Hydrus® Outcomes in the 5 year HORIZON Trial Graham Lee Hydrus® Microstent Surgical Implantation Steps Shamira Perera Integrating into Practice with Hydrus® Nathan Kerr Moderated Q&A Dr Chelvin Sng & Panel Brought to you by  |
||||
| Day 2 - Friday 5 August | |
|---|---|
|
Virtual sessions only |
|
|
0900-1030 |
MSJOC oral presentations
|
|
Chairpersons: Mae-Lynn Catherine Bastion and Teh Wee Min
|
|
|
In vitro and in vivo Biodegradation of PHA polymer: Regenerative Strategy for Corneal Application
Bakiah Shaharuddin Dry Eye Management with Diquafosol 3% Eyedrops Before and After Cataract Surgery Mun Wai Lee Machine learning for predicting childhood myopia progression Yong Li Conditioned Media from Mesenchymal Stem Cells Upregulates Corneal Epithelial Genes Expression on PHA Bakiah Shaharuddin Retinal neural dysfunction in diabetes revealed with handheld chromatic pupillometry Tan Tien-En Intra-arterial Chemotherapy for Retinoblastoma: 7-years outcomes in Malaysia Yong Zheng Wai Umbilical cord plasma therapy for recalcitrant dry eye disease in a local Singaporean context Joy Wong Q&A |
|
|
1030-1100 |
Break |
|
1100-1230 |
International Society of Glaucoma Surgery (ISGS) symposium: reducing risk in glaucoma surgery
|
|
Tubes in older patients as primary treatment
Andy Crichton Reducing variation in outcome of trabeculectomy Surinder Pandav Reducing needling rates in XEN implants Michael Coote Reducing rick in vulnerable and isolated patient groups Tarek Shaaraway Auditing risk management in surgery Kerr Brogan Managing the stent in GDD - tips and pearls Keith Barton Q&A |
|
|
1230-1300 |
Break |
|
1300-1430 |
APGC abstract session 2
|
|
Chairperson: Ningli Wang and Nazrul Islam
|
|
|
Effect of Trans-resveratrol on NMDA Induced Retinal Injury: Involvement of AA1R
Afiqq Aiman Incidence and factors associated with brimonidine allergy Sunee Chansangpetch Caregiver burden in Childhood Glaucoma Nidhi Chauhan Combined phaco-emulsification and trabecular micro-bypass stent (iStent inject) for management of cataract and glaucoma: prospective longitudinal outcomes from the Fight Glaucoma Blindness Registry Colin Clement Reduced intradisc vessel density is associated with optic disc hemorrhage in eyes with primary open-angle glaucoma Ko Eun Kim PreserFlo™ Microshunt: Safety and Efficacy Outcomes in Uveitic Glaucoma Jonathan Kirk Assessment of the Anterior Chamber Angle and Central Biometric Parameters with Hyperparallel Optical Coherence Tomography Natalia Porporato The efficacy and safety of prostaglandin analogues/ timolol fixed combinations in glaucoma and ocular hypertension: a systematic review and meta-analysis Parin Trabwongwitaya Iridolenticular Contact Area, Pupil Block and Primary Angle Closure Tin A Tun Low Optic Disc Perfusion Evaluated with Swept Source Optical Coherence Tomography Angiography is Associated with Visual Field Progression in Open Angle Glaucoma Jooyoung Yoon Q&A |
|
|
1430-1500 |
Break |
|
1500-1645 |
Trabeculectomy and GDD: How to improve outcomes
|
|
Chairpersons: Ikke Sumantri and Norshamsiah Md Din
Improving surgical technique of trabeculectomy Nazrul Islam Filtration surgery with stent Prin Rojanapongpun Rescuing of failing trab Michael Coote Improving outcome of GDD Paul Chew Managing cataract along with tubes surgery Ishtiaque Answar Fixing common complications of GDD Victor Koh Placement of GDD tube: anterior chamber or sulcus? Ch'ng Tun Wang Q&A |
|
|
1645-1700 |
Break |
|
1700-1830 |
Video symposium on challenging situations in glaucoma surgery
|
|
Chairpersons: Chan Yun Kim, Da Wen Lu and Gan Eng Hui
|
|
|
The art of deep sclerectomy
Andre Mermoud Filtration surgery at the inferior limbus - when and how Leon Au iStent misadventures & how to manage Bryan Ang Difficult xen implantation: stay zen Kaweh Mansouri How to restore a failing filter Vital Costa Ab interno repair of a cyclodialysis created while doing GSL Shamira Perera Difficult situations after tubes SS Pandav Surgical management of nanophthalmos with glaucoma Sirisha Senthil How to manage hypotony maculopathy Paul Palmberg Challenges in congenital glaucoma Alana Grajewski Q&A |
|
|
1730-2000 |
Hybrid wetlab featuring the Hydrus® Microstent Facilitators: Bryan Ang, Shamira Perera, Nathan Kerr delivery mode: in person only In-Person WetLab Session Hydrus® instructors delivery mode: in person only WetLab Virtual Broadcast delivery mode: in person and virtual broadcasting Didactic Session & Hands-On WetLab Nathan Kerr, Shamira Perera, Bryan Ang delivery mode: in person and virtual broadcasting Close Brought to you by |
| Day 3 - Saturday 6 August | ||
|---|---|---|
|
Hybrid sessions |
||
|
0815-0830 |
Opening of APGC 2022
Opening comments from APGC 2022 Congress Chair SK Fang Opening comments from APGS President Ki Ho Park Opening comments from MSJOC Congress Chair Hon Seng Wong Opening comments from MSO President Mano Shunmugan Opening comments from SSO President Lee Shu Yen |
|
|
0830-1000 |
PLENARY SESSION Hot topics in glaucoma |
|
|
Chairpersons: Paul Healey and Jemaima Che Hamzah
|
||
|
New IOP lowering agent
Reza Razeghinejad Micropulse trans-scleral cyclophotocoagulation: when? Who? Optimal setting? Shan Lin Multifocal IOL in glaucoma patients / EDOF IOLs Catherine Liu Visual rehabilitation for patient with glaucoma: where are we now? Liza Sharmini Ahmad Tajudin Aqueous outflow regulation - 21st century concepts Chen Xin Role of intraocular MIGS without conjunctival incision: when? who? tips for surgical success Kaweh Mansouri Optimising microtube implantation Peng Khaw Diagnostic accuracy of total macular thickness in glaucoma Mimiwati Zahari Q&A |
||
|
1000-1030 |
Break |
|
|
1030-1200 |
Paediatric Ophthalmology |
|
|
Chairpersons: Jamalia Rahmat, Lai Yi En and Tsiang Ung
|
||
|
Myopia progression and online learning
Safinaz Mohd Khialdin Acquired esotropia and digital eye strain Shatriah Ismail Pediatric craniosynostosis - a difficult year due to pandemic restrictions Choo May May Intraarterial chemotherapy in retinoblastoma Norhafizah Hamzah Refractive surgery in children Azura Ramlee Gene therapy in paediatric ophthalmology Chan Hwei Wuen Intermittent exotropia - early or late surgery Norazah Abdul Rahman Great mimics in paediatric ophthalmology Fazilawati A. Qamarrudin Panel discussion |
||
|
1200-1330 |
Lunch |
|
|
1215-1330 |
Expert Panel: The Three Wishes of Glaucoma Management - Early diagnosis, Effective treatment & Enhanced adherence Chair:Seng Kheong Fang Expert panel: Makoto Aihara, Ki Ho Park Brought to you by  |
|
|
1330-1500 |
PLENARY SESSION Current concepts in primary angle closure disease |
|
|
Chairperson: Mohd Aziz Husni
|
||
|
Effect of myopia and cataract surgery on burden of angle closure disease in Asia
Mingguang He Genetics of angle closure disease - what we have learnt? Tin Aung Evidence based management options for PACS, PAC and PACG Lingam Vijaya Diagnostic tools for angle closure disease - Gonioscopy or anterior segment OCT? Kyung Rim Sung Management options for acute primary angle closure (APAC) Clement Tham Internal drainage surgery - goniosynechialysis, MIGS and other newer options Xiulan Zhang Aqueous misdirection and other secondary angle closures Tetsuya Yamamoto Utility of AI in diagnosing PACD Benjamin Xu Q&A |
||
|
1500-1530 |
Break |
|
|
1530-1700 |
Cornea |
|
|
Chairpersons: K John Mathen and Marcus Ang
|
||
|
Clinical pearls in managing infectious keratitis
Chandramalar Santhirathelagan Allergic eye disease management Wan Haslina Descematopexy in descement's membrane detachment after cataract surgery Siti Nor Roha Management of OSSN Che Mahiran Role of contact lens in ocular surface disorder On Heong Liew DMEK - Learning curve and pearls to overcome Anshu Arundhati Panel discussion |
||
|
1530-1700 |
APGS Biennial GM Meeting |
|
|
1700-1800 |
DuoTrav® and Simbrinza® for IOP Lowering
Chair: Mimiwati Binti Zahari The Recent Advances in Glaucoma Management Tin Aung Brought to you by  |
|
|
1800-1900 |
Networking drinks |
|
|
1900-2030 |
European Glaucoma Society (EGS) symposium: Highlights from the EGS congress in Athens 2022 |
|
|
Chairperson: Luis Pinto and Ananth Viswanathan
|
||
|
EGS guidelines on surgical innovation
Luis Abegao Pinto Will genotyping change our everyday practice in the future Ananth Viswanathan Choosing wisely - avoid fiddling with timing of surgery while Rome burns Stylianos Kandarakis Can glaucoma be reversed with neuroregeneration? Keith Martin The EGS patient project Stelios Georgoulas Q&A |
||
| Day 4 - Sunday 7 August | |
|---|---|
|
Hybrid sessions |
|
|
0830-1000 |
Retina |
|
Chairpersons: Hon Seng Wong and Daniel Ting
|
|
|
Relevant imaging features in managing wet & dry AMD
Embong Zunaina Non-exudative AMD Daniel Ting Fluid or no fluid in managing AMD Tara Mary George Persistent fluid in neovascular AMD: optimising treatment regime Gavin Tan Learnings from local wet AMD patients: Pagenax related IOI Shelina Oli Mohamad Better efficacy and longer durability: new agents in management of wet AMD Wong Jun Shyan PCV: Is there still a role for PDT? Norfariza Ngah Challenging cases in AMD Barkeh Hanim Panel discussion |
|
|
0830-1000 |
APGS President’s Summit |
|
1000-1030 |
Break |
|
1030-1200 |
Minimally invasive glaucoma surgery |
|
Chairpersons: Colin Clement and Ng Hong Kee
|
|
|
Troubleshooting subconjunctival MIGS
Keith Barton Aqueous angiography guided MIGS Tanuj Dada Japanese clinical study of Preserflo Microshunt and its potential Makoto Aihara Surgical predictor of Xen Gel Stent Seungsoo Rho Advances in ab interno canaloplasty Nathan Kerr Suprachoroidal drainage Tarek Shaarawy Microhook ab-interno trabeculotomy Masaki Tanito Q&A |
|
|
1200-1330 |
Lunch |
|
1200-1300 |
MSO-SSO YO session
Introduction Chan Jan Bond Update from MSO YO Sudhashini Chandrasekaran Update from SSO YO Wong Chee Wai MSO-SSO YO potential collaboration: discussion session APAO YO rising stars program Marcus Ang YO to YO: residency, training and fellowship Pushpa Raman and Daniel Ting |
|
1330-1500 |
Cataract/refractive surgery |
|
Chairpersons: Lee Mun Wai and Zainah Alsagoff
|
|
|
Introduction and definition
Miswan Muiz Mayhudin Laser vision correction Miswan Muiz Mayhudin Implantable contact lens Mohamad Rosman Lens options for cataract and clear lens exchange Khairidzan Mohd Kamal Ocular biometry for high myopia Fam Han Bor Pearls for high myope cataract surgery Lee Mun Wai Q&A |
|
|
1500-1530 |
Break |
|
1530-1700 |
PLENARY SESSION APGS Presidential symposium: Imaging in glaucoma with OCT and AI |
|
Chairpersons: Tin Aung, Ki Ho Park and Liza Sharmini
|
|
|
Detection of early glaucoma using OCT
Joel Schuman AI in glaucoma care Felipe Medeiros OCT in myopic glaucoma Ki Ho Park Estimation of the central 10-degree visual field using en-face images obtained by optical coherence tomography Takeo Fukuchi AI in glaucoma diagnosis and prediction Xiulan Zhang Describing the structure and biomechanical phenotype of glaucoma using AI Michael Girard Glaucoma diagnostics in the era of high-resolution imaging and AI: a new horizon Jin Wook Jeoung Q&A |
|
|
1700-1830 |
Awards symposium and closing ceremony |
|
Chairperson: Jelinar Mohamed Noor and SK Fang
|
|
|
APGC and MSJOC awards
- APGC 2022 best free paper oral award - APGC Film Festival award - MSJOC best paper oral award - MSJOC best paper poster award Young Investigator Award presentation Chelvin Sng Asia Pacific Award presentation: Optic disc hemorrhage and its clinical significance Tetsuya Yamamoto International Award presentation Neeru Gupta Keshmahinder Singh Oration: Innovations and advances in translational research Peng Khaw MGS Distinguished Service Award Ropilah Abdul Rahman MSO Keynote Lecture: Diabetic vitrectomy - is there still a role in the age of anti-VEGF? Lee Shu Yen |
|
| PROGRAM | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0800-0900 |
Concurrent Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. |
Concurrent Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. |
Concurrent Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. |
Concurrent Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. |
||||||||||
|
0900-1030 |
Plenary session Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. |
|||||||||||||
|
1030-1045 |
BREAK |
|||||||||||||
|
1045-1225 |
Concurrent Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. |
Concurrent Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. |
Concurrent Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. |
Concurrent Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. |
||||||||||
|
1225-1345 |
Lunch industry symposium |
Lunch industry symposium |
||||||||||||
|
1345-1445 |
BREAK |
|||||||||||||
|
1345-1445 |
Poster Viewing |
|||||||||||||
|
1445-1625 |
Concurrent Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. |
Concurrent Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. |
Concurrent Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. |
Concurrent Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. |
||||||||||
|
1625-1700 |
Closing Ceremony Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. |
|||||||||||||
| PROGRAM | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0800-0900 |
Concurrent Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. |
Concurrent Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. |
Concurrent Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. |
Concurrent Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. |
||||||||||
|
0900-1030 |
Plenary session Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. |
|||||||||||||
|
1030-1045 |
BREAK |
|||||||||||||
|
1045-1225 |
Concurrent Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. |
Concurrent Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. |
Concurrent Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. |
Concurrent Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. |
||||||||||
|
1225-1345 |
Lunch industry symposium |
Lunch industry symposium |
||||||||||||
|
1345-1445 |
BREAK |
|||||||||||||
|
1345-1445 |
Poster Viewing |
|||||||||||||
|
1445-1625 |
Concurrent Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. |
Concurrent Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. |
Concurrent Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. |
Concurrent Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. |
||||||||||
|
1625-1700 |
Closing Ceremony Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. |
|||||||||||||
| PROGRAM | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0800-0900 |
Concurrent Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. |
Concurrent Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. |
Concurrent Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. |
Concurrent Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. |
||||||||||
|
0900-1030 |
Plenary session Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. |
|||||||||||||
|
1030-1045 |
BREAK |
|||||||||||||
|
1045-1225 |
Concurrent Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. |
Concurrent Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. |
Concurrent Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. |
Concurrent Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. |
||||||||||
|
1225-1345 |
Lunch industry symposium |
Lunch industry symposium |
||||||||||||
|
1345-1445 |
BREAK |
|||||||||||||
|
1345-1445 |
Poster Viewing |
|||||||||||||
|
1445-1625 |
Concurrent Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. |
Concurrent Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. |
Concurrent Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. |
Concurrent Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. |
||||||||||
|
1625-1700 |
Closing Ceremony Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. |
|||||||||||||
